The effect of the combined contraceptive with chlormadinone acetate in the dermatological and psychosocial status of patients with acne


Cite item

Full Text

Abstract

The article is about assessing the effectiveness of the treatment of acne of varying severity using a combined hormonal contraceptive Belara® and its impact on the indicators of psychological and social status of women of reproductive age. The study included 123 women interested in contraception, aged 18-45 years old with acne on the face of varying severity. A survey on subjective and objective assessment of the condition of the skin and the presence of psychological and social problems associated with acne, after 3 and 6 cycles of using Belara®. It has been shown that the combined oral contraceptive Belara® containing in its composition ethinylestradiol and chlormadinone acetate, is well tolerated and effective in improving skin condition in patients with acne, that has a positive impact on their psychological, emotional and social self-esteem. High satisfaction drug indicated 87% of the patients.

About the authors

N E Vorobyova

D.O.Ott Research Institute of Obstetrics, Gynecology and Reproduction

Email: sergiognezdo@yandex.ru
канд. мед. наук, науч. сотр. отд-ния гинекологической эндокринологии ФГБНУ НИИ акушерства, гинекологии и репродуктологии им. Д.О.Отта 199034, Russian Federation, Saint Petersburg, Mendeleevskaia liniia, d. 3

M A Tarasova

D.O.Ott Research Institute of Obstetrics, Gynecology and Reproduction

Email: tarasova@ott.ru
д-р мед. наук, проф., рук. отд-ния гинекологической эндокринологии ФГБНУ НИИ акушерства, гинекологии и репродуктологии им. Д.О.Отта 199034, Russian Federation, Saint Petersburg, Mendeleevskaia liniia, d. 3

References

  1. Goulden V, Stables G, Gunliffe W. Prevalence of facial acne in adults. J Fv Acad Derm 1999; 44: 577-80.
  2. Zouboulis C.C. The human skin as a hormone target and an endocrine gland. Hormones 2004; 3 (1): 9-26.
  3. Held B.L, Nader S, Rodriguez-Rigau L.J et al. Acne and hyperandrogenism. J Am Acad Dermatol 1984; 10 (2 Pt. 1): 223-6.
  4. Lucky A.W. Hormonal correlates of acne and hirsutism. Am J Med 1995; 98 (1A): 89S-94S.
  5. Rosenfield R.L, Deplewski D. Role of androgens in the developmental biology of the pilosebaceous unit. Am J Med 1995; 98 (1A): 80S-88S.
  6. Huber J.C, Heskamp M.L, Schramm G.A. Effect of an oral contraceptive with chlormadinone acetate on depressive mood: analysis of data from four observational studies. Clin Drug Investig 2008; 28 (12): 783-91.
  7. Vasques M.G, Amayueles R.N, Lamarca M et al. Ethinylestradiol/Chlormadinon acetate for use in dermatological disorders. Am J Clin Dermatol 2011; 12 (Suppl. 1): 13-9.
  8. Guerra-Tapia A, Sancho Pérez B. Ethinylestradiol/Chlormadinone acetate: dermatological benefits. Am J Clin Dermatol 2011; 12 (Suppl. 1): 3-11.
  9. Шестакова И.Г., Бриль Ю.А. Женские андрогены: ищем золотую середину. StatusPrezens. 2014; 4 (21): 55-60.
  10. Kerscher M, Reuther T, Bayrhammer J, Schramm G. Effects of an oral contraceptive containing chlormadinone and ethinylestradiol on acne - prone skin of women of different age groups: an open - label, single - centre, phase IV study. Clin Drug Investig 2008; 28 (11): 703-11.
  11. Térouanne B, Paris F, Servant N et al. Evidence that chlormadinone acetate exhibits antiandrogenic activity in androgen - dependent cell line. Mol Cell Endocrinol 2002; 198 (1-2): 143-7.
  12. Schramm G, Steffens D. Contraceptive efficacy and tolerability of chlormadinone acetate 2 mg/ethinylestradiol 0,03 mg (BelaraR). Results of a post - marketing surveillance study. Clin Drug Invest 2002; 22: 221-31.
  13. Schramm G, Steffens D. F 12-month evaluation of the CMA-containing pral contraceptive Belara: efficacy, tolerability and anti - androgenic properties. Contraception 2003; 67: 305-12.
  14. Zahradnik H, Goldberg J, Andreas J. Efficacy and safety of the new antiandrogenic oral contraceptive Belara. Contraception 1998; 57: 103-9.
  15. Zahradnik H.P, Hanjalic-Dtck A. Efficacy, safety and sustainability of treatment continuation and results of an oral contraceptive containing 30 mcg ethinylestradiol and 2 mg chlormadinone acetate, in long - term usage (up to 45 cycles) - an open - label, prospective, noncontrolled, office - based Phase III study. Contraception 2008; 77: 337-43.
  16. Arowojolu A.O, Gallo M.F, Lopez L.M et al. Combined oral contraceptive pills for treatment of acne. Cochrane Database Syst Rev 2007; CD004425.
  17. Worret I, Arp W, Zahradnik H.P et al. Acne resolution rates: results of a single - blind, randomized, controlled, parallel phase III trial with EE/CMA (Belara) and EE/LNG (Microgynon). Dermatology 2001; 203 (1): 38-44.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2016 Consilium Medicum

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Согласие на обработку персональных данных

 

Используя сайт https://journals.rcsi.science, я (далее – «Пользователь» или «Субъект персональных данных») даю согласие на обработку персональных данных на этом сайте (текст Согласия) и на обработку персональных данных с помощью сервиса «Яндекс.Метрика» (текст Согласия).